Tracks adults with kidney cyst disease considered for tolvaptan treatment
Records real-world care of adults with polycystic kidney disease who may receive tolvaptan.
Plain-language title generated from the registry record
Registry title: The German ADPKD Tolvaptan Treatment Registry
Key facts
- Where
- Berlin, Cologne, Hanover, Jena, Leipzig, Lübeck, Müllheim, Nettetal, Stuttgart, and Würzburg, GermanySee the 12 sites
Where in Germany
- Charité Universitätsmedizin BerlinBerlin, GermanyNo longer taking part
- University Hospital of CologneCologne, GermanyTaking people
- Medizinische Hochschule HannoverHanover, GermanyTaking people
- University Hospital of JenaJena, GermanyTaking people
- Praxisgemeinschaft Dr. PeschelLeipzig, GermanyTaking people
- University Hospital of Leipzig, Nephrologische AmbulanzLeipzig, GermanyTaking people
- Nierenzentrum LübeckLübeck, GermanyTaking people
- University Hospital of Schleswig-HolsteinLübeck, GermanyTaking people
- Fachinternistische Gemeinschaftspraxis MarkgraeferlandMüllheim, GermanyTaking people
- Nieren- und Diabeteszentrum Nettetal-LobberichNettetal, GermanyNo longer taking part
- Robert Bosch KrankenhausStuttgart, GermanyTaking people
- University Hospital of Wuerzburg, ZIMWürzburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Cologne
- Trial code
- NCT02497521
- Record updated
- 30 April 2026
- Original description
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.Read full original descriptionShow less
The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.
Inclusion: Age > 18 years; ADPKD proven by positive family history and evidence of renal cysts or diagnosed by treating physician; Presentation at our center for tolvaptan treatment indication, or tolvaptan treatment planned, or tolvaptan already started.
Exclusion: Patients receiving tolvaptan as "off-label use"; End stage renal disease requiring renal replacement therapy; Patients not capable of giving informed consent.